AVS Bio, an Arlington Capital Partners Portfolio Company, Acquires Biorbyt Ltd.

NORWICH, Conn.--(BUSINESS WIRE)--AVS Bio (the “Company”), a leading global provider of critical inputs and services for the bioprocessing and biologics industries, today announced it has acquired Biorbyt Ltd. (“Biorbyt”), a global supplier of high-quality bio-reagents, antibodies, proteins, and other biomaterials for life science research. The acquisition significantly expands AVS Bio’s catalog of research products and global distribution capabilities through Biorbyt’s advanced ecommerce platfo